购物车
- 全部删除
- 您的购物车当前为空
GW 583340 dihydrochloride是一种高效和可口服的双重EGFR/ErbB2(表皮生长因子受体/酪氨酸激酶)抑制剂,并且能够逆转ABCG2和ABCB1介导的耐药性。GW 583340 dihydrochloride能够选择性地抑制过表达EGFR和ErbB2的人类肿瘤细胞的生长,在小鼠异种移植模型中抑制80%的肿瘤生长,具有潜在的抗癌活性。
为众多的药物研发团队赋能,
让新药发现更简单!
GW 583340 dihydrochloride是一种高效和可口服的双重EGFR/ErbB2(表皮生长因子受体/酪氨酸激酶)抑制剂,并且能够逆转ABCG2和ABCB1介导的耐药性。GW 583340 dihydrochloride能够选择性地抑制过表达EGFR和ErbB2的人类肿瘤细胞的生长,在小鼠异种移植模型中抑制80%的肿瘤生长,具有潜在的抗癌活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,230 | 现货 | |
5 mg | ¥ 2,820 | 现货 | |
10 mg | ¥ 3,970 | 现货 | |
25 mg | ¥ 6,430 | 现货 | |
50 mg | ¥ 8,670 | 现货 | |
100 mg | ¥ 11,600 | 现货 |
产品描述 | GW 583340 dihydrochloride is a potent and orally available dual EGFR/ErbB2 (epidermal growth factor receptor/tyrosine kinase) inhibitor and is capable of reversing ABCG2- and ABCB1-mediated resistance.GW 583340 dihydrochloride selectively inhibits the growth of human tumor cells overexpressing EGFR and ErbB2, selectively inhibits the growth of human tumor cells overexpressing EGFR and ErbB2, and inhibits 80% of tumor growth in a mouse xenograft model, with potential anticancer activity. |
别名 | GW583340 dihydrochloride |
分子量 | 671.03 |
分子式 | C28H27Cl3FN5O3S2 |
CAS No. | 1173023-85-2 |
Smiles | O=S(C)(CCNCC1=NC(C2=CC3=C(NC4=CC=C(C(Cl)=C4)OCC5=CC(F)=CC=C5)N=CN=C3C=C2)=CS1)=O.Cl.Cl |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40 mg/mL (59.61 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
评论内容